Hepatitis B: Who to treat? A critical review of international guidelines-Reference-Cited by-同舟云学术

Hepatitis B: Who to treat? A critical review of international guidelines

Published:2020-02 Issue:S1 Volume:40 Page:5-14
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Huang Daniel Q.¹²,Lim Seng Gee¹²^ORCID

Affiliation:

1. Division of Gastroenterology and Hepatology Department of Medicine National University Hospital Singapore Singapore

2. Department of Medicine Yong Loo Lin School of Medicine National University of Singapore Singapore Singapore

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14365

Reference14 articles.

1. WHO.WHO | Global hepatitis report.2017.http://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/. Accessed July 12 2018.

2. Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis

3. WHO.WHO | Guidelines for the prevention care and treatment of persons with chronic hepatitis B infection.http://www.who.int/hepatitis/publications/hepatitis-b-guidelines/en/. Accessed September 20 2019.

4. Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors

5. Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of hepatitis B virus relapse in cancer patients receiving chemotherapy with prophylactic nucleos(t)ide analogues: Implications for overall mortality;Liver International;2024-07-10

2. Quantitative HBeAg is a strong predictor of HBeAg loss among patients receiving pegylated interferon;Antiviral Research;2024-07

3. Analysis of primary care electronic health record data of people living with hepatitis B virus: infection and hepatocellular carcinoma risk associated with socio-economic deprivation;Public Health;2024-01

4. Optimizing care of HBV infection and HBV-related HCC;Clinical Liver Disease;2024-01

5. A decision-making model for prediction of a stable disease course in chronic hepatitis B patients;Scientific Reports;2023-12-27